Frequently Asked Questions

Yes. Colorado's Natural Medicine Health Act (Proposition 122), passed in November 2022, legalized psilocybin-assisted therapy under a regulated framework. The program became fully operational in 2025, with licensed healing centers and facilitators serving adults 21 and older statewide.

In supervised clinical settings, psilocybin has a strong safety profile. Clinical trials at institutions like Johns Hopkins and NYU have consistently shown it to be well-tolerated. Thorough screening, trained facilitators, and controlled environments are essential to ensuring safety — which is why working with a licensed provider matters.

Common temporary effects include headache, nausea, emotional intensity, and fatigue. These typically resolve within 24 hours. Psilocybin is not recommended for individuals with a personal or family history of psychotic disorders, certain heart conditions, or those taking specific medications. A comprehensive screening process helps identify any contraindications.

We use psilocybin derived from natural mushrooms, as regulated under Colorado's Natural Medicine Health Act. The Act covers naturally occurring psychedelic substances including psilocybin, psilocin, DMT, ibogaine, and mescaline (excluding peyote). Our focus is on psilocybin, which has the most extensive clinical research supporting its therapeutic use.

The process has three phases: Preparation (setting intentions, education, screening), the Psilocybin Session (a 4-6 hour guided experience in a safe clinical environment), and Integration (follow-up therapy to process insights and apply them to daily life). This structured approach is based on the protocols used in clinical research trials.

Preparation involves several elements: building a therapeutic relationship with your facilitator, setting clear intentions, making lifestyle adjustments (such as diet and sleep), and educating yourself about the experience. We guide you through every step to ensure you feel informed, comfortable, and ready.

Integration is the process of making sense of your psychedelic experience and translating insights into lasting changes in your life. It's often considered the most important phase of psychedelic therapy. Through follow-up sessions, we help you process emotions, reinforce new perspectives, and develop practical strategies for sustained growth.

A typical psilocybin session lasts 4 to 6 hours, though you should plan for a full day. This includes time for settling in, the experience itself, and a period of coming down and initial processing afterward. Your facilitator is present throughout the entire session.

Research shows promise for treatment-resistant depression, PTSD and trauma, anxiety disorders (including cancer-related anxiety), end-of-life distress, addiction, and general personal development. The strongest evidence currently exists for depression and anxiety, but research is expanding rapidly across many conditions.

Psilocybin therapy is generally not recommended for individuals with a personal or family history of psychotic disorders (such as schizophrenia or bipolar I), certain cardiovascular conditions, those currently taking lithium or certain other medications, or individuals in acute crisis. A thorough screening process helps determine appropriateness.

No referral is needed. While many clients come to us with diagnosed conditions, you don't need a formal diagnosis or referral from another provider to explore psilocybin therapy. Our screening process will help determine whether this approach is right for your situation.

This varies by individual. Some people experience significant benefits from a single psilocybin session, while others benefit from a series of 2-3 sessions. Each session includes its own preparation and integration work. We'll develop a personalized plan based on your goals and response to treatment.

Currently, psilocybin therapy is not covered by insurance. Sessions are self-pay, with costs in the range of $1,000-$3,000 depending on the scope of treatment. As the field evolves and more evidence accumulates, insurance coverage may become available in the future.

We serve the greater Denver metro area, with a focus on the south Denver corridor including the Denver Tech Center, Greenwood Village, Centennial, and surrounding communities. Specific location details will be shared upon inquiry.

Major research institutions including Johns Hopkins, NYU, and Imperial College London have published compelling results. Studies show significant improvements in depression (with effects lasting months after a single dose), PTSD symptom reduction (81.8% response rate in a Phase 2 trial), and reduced anxiety in cancer patients (80% experienced sustained relief). The FDA has designated psilocybin a "breakthrough therapy" for depression.

Psilocybin converts to psilocin in the body, which primarily interacts with serotonin (5-HT2A) receptors. This promotes neuroplasticity — the brain's ability to form new connections. It also temporarily reduces activity in the "default mode network," the brain region associated with rigid thought patterns and self-referential thinking. This combination may explain why psilocybin can help break entrenched mental health patterns.

No. Psilocybin has very low addiction potential. It does not produce physical dependence, and tolerance builds rapidly (making frequent use self-limiting). Research consistently places psilocybin among the least addictive of all psychoactive substances. In fact, studies are exploring whether psilocybin can help treat addiction to other substances.